By InvitationNot Applicable

Comparison Between Intravenous Hydrocortisone and Ondansetron in Prevention of Post Spinal Anesthesia Hypotension

Egypt120 participantsStarted 2024-03-01

Plain-language summary

The purpose of this study is to assess and contrast the effectiveness of intravenous ondansetron and intravenous hydrocortisone in avoiding spinal anesthesia-induced hypotension.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. ASA I and II (physical status according to American Society of Anesthesiologists).
✓. Patients aged 21 years or more.
✓. Either sex.
✓. Abdominal and lower limb operations.

Exclusion criteria

✕. Patient refusal.
✕. hemodynamic instability
✕. Hematological diseases, bleeding or coagulation abnormality.
✕. Local skin infection and sepsis at site of spinal anesthesia
✕. neuromuscular diseases (as myopathies, myasthenia gravies…)
✕. Preexisting neurological deficit or psychiatric diseases.
✕. Known intolerance to the study drugs.
✕. patients already receiving any of the study drugs.

What they're measuring

hypotension

Timeframe: 5 minutes after subarachnoid injection and every 5 minutes for 30 minutes-duration

Trial details

NCT IDNCT06930456

SponsorNada kamel Elgamal

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-01

View on ClinicalTrials.gov More Post Spinal Anaesthesia Hypotension trials